Two Slovenian Pharma Companies Vying for Supremacy in Russia
Ljubljana, 21 March - Pharmaceutical company Lek, a part of the Swiss giant Novartis, made it its goal last year to leapfrog its Slovenian rival Krka as the leader on the Russian market. This is what outgoing Lek CEO said in an interview published on Monday.
The rest of this news item is available to subscribers.
The news item consists of 1.308 characters (without spaces) or 275 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.